IPRIPR2023-00551Terminated-Settled
Fusion Pharmaceuticals, Inc.v.UNIVERSITÄT HEIDELBERG et al.
IPR challenge of US 10980901.
Type
IPR
Filed
Feb 13, 2023
Instituted
Aug 15, 2023
Decided
Mar 12, 2024
Patent
Application
16470104
Inventor
Alfred MORGENSTERN et al
Granted
Apr 20, 2021
01
Timeline
3 milestones
2023-02-13Petition filed
2023-08-15Institution
2024-03-12Terminated
02
Parties & counsel
Petitioner
Fusion Pharmaceuticals, Inc.
Counsel
Cipriano, Linneaet al
Patent Owner
UNIVERSITÄT HEIDELBERG et al.
Counsel
Hasan, S. Artet al
03
Docket
Documents are mirrored from the PTAB e-file system. Filer is as stated on the face of the filing.
SOURCE · USPTO PTAB E2EView on Unified Patents →